Vai al contenuto principale della pagina

Drug truths [[electronic resource] ] : dispelling the myths about pharma R&D / / John L. LaMattina



(Visualizza in formato marc)    (Visualizza in BIBFRAME)

Autore: LaMattina John L Visualizza persona
Titolo: Drug truths [[electronic resource] ] : dispelling the myths about pharma R&D / / John L. LaMattina Visualizza cluster
Pubblicazione: Hoboken, N.J., : John Wiley & Sons, c2009
Descrizione fisica: 1 online resource (156 p.)
Disciplina: 338.4761519
615/.19
Soggetto topico: Drug development - United States
Pharmaceutical industry - United States
Drugs - Research - United States
Soggetto genere / forma: Electronic books.
Note generali: Description based upon print version of record.
Nota di bibliografia: Includes bibliographical references (p. 124-132) and index.
Nota di contenuto: Cholesterol drugs are unnecessary -- Industry is more interested in 'me-too' drugs than in innovation -- It takes industry too long to discover new drugs -- Drugs are discovered by academia -- New medicines add costs but little benefit -- Big pharma has failed and should learn from biotech success -- The industry invents diseases -- New drugs are less safe than traditional medicines -- Industry spends more on advertising than R&D -- Industry does not care about diseases of the developing world -- Big pharma's day has passed -- Final reflections.
Sommario/riassunto: This book answers the questions about the process and costs of pharmaceutical R & D in a compelling narrative focused on the discovery and development of important new medicines. It gives an insider's account of the pharmaceutical industry drug discovery process, the very real costs of misperceptions about the industry, the high stakes--both economic and scientific--of developing drugs, the triumphs that come when new compounds reach the market and save lives, and the despair that follows when new compounds fail. In the book, John LaMattina, former president of Pfizer Global Research and Devel
Titolo autorizzato: Drug truths  Visualizza cluster
ISBN: 1-118-15896-2
1-281-93930-7
9786611939304
0-470-43467-8
0-470-43465-1
Formato: Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione: Inglese
Record Nr.: 9910144118603321
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui